Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis

Technology appraisal guidance
Reference number: TA373
Published: 16 December 2015

History

Expected publication

Equality Impact Assessment (Guidance development) (PDF 228 KB)

Published:

14 December 2016

Final appraisal determination

Final appraisal determination
Final appraisal determination document (PDF 248 KB)

Published:

22 October 2015
Committee papers (PDF 11.25 MB)

Published:

22 October 2015

Assessment report

Assessment report (PDF 2.47 MB)

Published:

03 August 2015

Final protocol

Final protocol (PDF 184 KB)

Published:

21 January 2015

Final scope

Final scope (PDF 43 KB)

Published:

27 November 2014

Final matrix

Final matrix (PDF 34 KB)

Published:

27 November 2014

Comments table

Comments table (PDF 157 KB)

Published:

27 November 2014

Equality impact assessment - scoping

Equality impact assessment - scoping (PDF 17 KB)

Published:

27 November 2014

Provisional matrix - July 2014

Provisional matrix - July 2014 (PDF 28 KB)

Published:

05 August 2014

Draft scope - July 2014

Draft scope - July 2014 (PDF 45 KB)

Published:

05 August 2014